In August 2016, I published an article entitled “To GAAP or NON-GAAP, That Is The Question” that discussed how we here at Geo Investing like to approach the topic of GAAP vs. adjusted earnings. Our team spends every morning reading […]
Colossal declines in the shares of Valeant Pharmaceuticals (NYSE:VRX) and Endo International (NMS:ENDP) wiped out billions of investor capital. The companies’ loose application of accounting guidelines has made the Generally Accepted Accounting Principles (GAAP) vs. non-GAAP (adjusted) debate a hot topic. Unfortunately, when issues […]